ARTICLE | Company News
OncoVista, TATAA Molecular Diagnostics deal
February 1, 2010 8:00 AM UTC
OncoVista's AdnaGen AG subsidiary granted TATAA exclusive rights to use its AdnaTest BreastCancer assay in the COHERTA project. The diagnostic uses RT-PCR to detect biomarkers in circulating tumor c...